Zeekr Group Announces May 2025 Delivery Update
In May, Zeekr Group delivered a total of 46,538 vehicles across its Zeekr and Lynk & Co brands, reflecting a 15.2% year-over-year growth and 12.6% increase compared to the previous month. This accomplishment was realized thanks to the trust and support of nearly 1.95 million users. In particular, the Zeekr brand delivered 18,908 vehicles, while Lynk & Co delivered 27,630 vehicles.
About Zeekr Group
Zeekr Group, headquartered in Zhejiang, China, is the world's leading premium new energy vehicle group from Geely Holding Group. With two brands, Lynk & Co and Zeekr, Zeekr Group aims to create a fully integrated user ecosystem with innovation as a standard. Utilizing its state-of-the-art facilities and world-class expertise, Zeekr Group is developing its own software systems, e-powertrain and electric vehicle supply chain. Zeekr Group's values are equality, diversity, and sustainability. Its ambition is to become a true global new energy mobility solution provider.
For more information, please visit https://ir.zeekrgroup.com.
Safe Harbor Statement
This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as "may," "will," "expect," "anticipate," "future," "target," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to," or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.
Investor Relations Contact
In China:
ZEEKR Intelligent Technology Holding LimitedInvestor RelationsEmail: ir@zeekrlife.com
Piacente Financial CommunicationsTel: +86-10-6508-0677Email: Zeekr@thepiacentegroup.com
In the United States:
Piacente Financial CommunicationsBrandi PiacenteTel: +1-212-481-2050Email: Zeekr@thepiacentegroup.com
Media Contact
Email: Globalcomms@zeekrgroup.com
View original content:https://www.prnewswire.com/news-releases/zeekr-group-announces-may-2025-delivery-update-302470079.html
SOURCE ZEEKR Intelligent Technology Holding Limited
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
25 minutes ago
- Bloomberg
US and China Are Expected to Extend Trade Truce by 90 Days, SCMP Says
US and China are expected to extend their tariff truce by another three months, the South China Morning Post reported, citing unnamed sources. The two countries will not impose additional tariffs on each other during the extension, one of the sources told the newspaper. The current pause was to end Aug. 12.
Yahoo
an hour ago
- Yahoo
UBS Raises PT on Lam Research Corporation (LRCX) from $95 to $120
Lam Research Corporation (NASDAQ:LRCX) secures a place on our list of the . the-main-processor-3334336_1280 On July 21, 2025, UBS increased its price target on Lam Research Corporation (NASDAQ:LRCX) from $95 to $120, maintaining a 'Buy' rating. This revision comes amid growing optimism for the company's Q4 performance. The analyst attributed the optimism to ongoing NAND equipment upgrades by Samsung, potential upside from TSMC, and strong demand out of China. Furthermore, the analyst expressed a positive outlook on the wafer fabrication equipment (WFE) market environment and Lam Research Corporation (NASDAQ:LRCX)'s positioning. Therefore, with investments ramping up globally in the semiconductor market, LRCX seems to be well-positioned to capitalize on the chipmaking demand surge. Lam Research Corporation (NASDAQ:LRCX), serving major foundries and integrated device manufacturers worldwide, manufactures advanced semiconductor processing equipment for chip production. It is one of the best ESG stocks. While we acknowledge the potential of LRCX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 14 Cheap Transportation Stocks to Buy According to Analysts and Top 10 AI Infrastructure Stocks to Buy Now. Disclosure: None. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Pfizer Inc. (PFE) Finalizes Global Licensing Agreement with 3sbio, Inc.
Pfizer Inc. (NYSE:PFE) is among the . On July 24, 2025, Pfizer Inc. (NYSE:PFE) finalized the global licensing agreement with 3SBio, Inc. With this agreement, PFE acquired the exclusive rights to develop, manufacture, and commercialize 3SBio's SSGJ-707, a bispecific antibody for PD-1 and VEGF. Leveraging 3SBio's proprietary CLF2 platform, this innovative treatment enhances Pfizer's oncology pipeline and solidifies its competitive edge in cancer research. The antibody is presently undergoing clinical trials in China for non-small cell lung cancer (NSCLC) with promising interim Phase 2 results. It is also under clinical trials for gynecological tumors. By manufacturing the drug in the U.S. and expanding clinical trials globally, Pfizer Inc. (NYSE:PFE) aims to focus on Phase 3 studies for NSCLC and other solid tumors. Pfizer Inc. (NYSE:PFE) will make an upfront payment of $1.25 billion to 3SBio and acquire a $100 million equity stake, as per the agreed terms. With up to $150 million in potential payments, Pfizer Inc. (NYSE:PFE) can exercise the option to extend the agreement for exclusive rights in China. Operating globally, Pfizer Inc. (NYSE:PFE) discovers, develops, and sells biopharmaceuticals. It is one of the best ESG stocks. While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and 11 Best Mineral Stocks to Buy According to Hedge Funds. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
